- $3.15bn
- $11.35bn
- $6.40bn
- 78
- 92
- 45
- 83
Annual income statement for Organon & Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6,532 | 6,304 | 6,174 | 6,263 | 6,403 |
| Cost of Revenue | |||||
| Gross Profit | 4,413 | 3,929 | 3,930 | 3,748 | 3,715 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,780 | 4,775 | 5,052 | 5,590 | 5,596 |
| Operating Profit | 2,752 | 1,529 | 1,122 | 673 | 807 |
| Net Income Before Taxes | 2,752 | 1,529 | 1,122 | 673 | 807 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2,256 | 1,351 | 917 | 1,023 | 864 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 2,160 | 1,351 | 917 | 1,023 | 864 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2,160 | 1,351 | 917 | 1,023 | 864 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 9.11 | 5.63 | 4.26 | 4.18 | 3.72 |
| Dividends per Share |